Immune Checkpoint Inhibitors in Melanoma: A Review of Pharmacokinetics and Exposure–Response Relationships

Clinical Pharmacokinetics - United Kingdom
doi 10.1007/s40262-019-00789-7
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Immune Checkpoint Inhibitors in Melanoma: Review and Update

Journal of the Portuguese Society of Dermatology and Venereology
2018English

Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy With Immune Checkpoint Inhibitors

Revista da Sociedade Portuguesa de Dermatologia e Venereologia
2018English

Recurrent Pneumonitis in Patients With Melanoma Treated With Immune Checkpoint Inhibitors

Oncologist
Cancer ResearchMedicineOncology
2019English

Review of Cancer Treatment With Immune Checkpoint Inhibitors

Wiener Klinische Wochenschrift
Medicine
2017English

Retreatment With Immune Checkpoint Inhibitors in Solid Tumors: A Systematic Review

2020English

Immune Checkpoint Inhibitors and irAEs

Trends in Immunotherapy
2018English

H3K27me3 and EZH2 Expression in Melanoma: Relevance for Melanoma Progression and Response to Immune Checkpoint Blockade

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2020English

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease

Gastroenterology
HepatologyGastroenterology
2018English

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review

Cancers
Cancer ResearchOncology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy